Dermata Therapeutics Stock (NASDAQ: DRMA) stock price, news, charts, stock research, profile.
You can purchase shares of Dermata Therapeutics (NASDAQ:DRMA) through any online brokerage.
Other companies in Dermata Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN) and Can Fite Biofarma (AMEX:CANF).
Dermata Therapeutics has a consensus price target of $6.00.
The stock price for Dermata Therapeutics (NASDAQ: DRMA) is $1.17 last updated February 14, 2025 at 7:48 PM EST.
There are no upcoming dividends for Dermata Therapeutics.
Dermata Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
There is no upcoming split for Dermata Therapeutics.
Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.